| [1] |
Crawford ED, Wilson SS, McConnell JD, et al. Baseline factorsas predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo[J].J Urol, 2006, 175(4): 1422-1427.
|
| [2] |
Armitage JN, Sibanda N, Cathcart PJ, et al. Mortality in men admitted to hospital with acute urinary retention: database analysis[J].BMJ, 2007, 335(7631): 1199-1202.
|
| [3] |
那彦群，叶章群，王建业，等．中国泌尿外科疾病诊断治疗指南[M]．北京：人民卫生出版社，2014：245-266.
|
| [4] |
张耀光，王建业，万奔，等．中国以前列腺体积增大为特点的良性前列腺增生症患者的临床特点[J]．中华泌尿外科杂志，2012，33(10): 782-785.
|
| [5] |
Pan JG, Jiang C, Luo R, et al. Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades[J]. Urol Int, 2013, 93(1): 10-16.
|
| [6] |
Mauro G, Giovanni C, Linda V, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis[J].BJU Int, 2015, 115(1): 24-31.
|
| [7] |
孙超，薛向东，汪柏林，等．良性前列腺增生与代谢综合征的相关性研究[J]．中国医科大学学报，2015，44(1): 15-19.
|
| [8] |
李莺，杨军，姚麒，等．良性前列腺增生临床进展与代谢综合征各成分的回归模型研究[J]．中国医科大学学报，2013，42(5): 394-398.
|
| [9] |
Wang S, Mao Q, Lin Y, et al. Body mass index and risk of BPH: a meta-analysis[J]. Prostate Cancer Prostatic Dis, 2012, 3(15): 265-272.
|
| [10] |
Yim SJ, Cho YS, Joo KJ, et al. Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age[J]. Korean J Urol, 2011, 52(6): 390-395.
|
| [11] |
Park Y, KimSB, Kwon H, et al. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome[J]. Urology, 2013, 82(3): 674-679.
|
| [12] |
Gustafson B, Hammarstedt A, Andersson CX, et al. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis[J]. Arterioscler ThrombVasc Biol, 2007, 27(11): 2276-2283.
|
| [13] |
Giorgio IR, Sebastiano C, Eugenia F, et al. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a ross-sectional study[J]. J Sex Med, 2014, 11(8): 2074-2082.
|
| [14] |
Zhang X, Zeng X, Liu Y, et al. Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men[J].Urol Int, 2014, 93(2): 214-219.
|
| [15] |
虞欣，王超，郭晓青，等．老年代谢综合征合并良性前列腺增生112例临床分析[J]．河北医科大学学报，2012，33(7): 753-755.
|
| [16] |
Vikram A, Jena G, Ramarao P. Insulin-resistance reduces botulinum neurotoxin-type A induced prostatic atrophy and apoptosis in rats[J].Eur J Pharmacol, 2011, 650(1): 356-363.
|
| [17] |
苗莉，陈哲，高春英，等．代谢综合征对老年良性前列腺增生的影响研究[J]．现代医药卫生，2013，29(10): 1446-1450.
|
| [18] |
褚琳，苗懿德，陈陵霞．代谢综合征与良性前列腺增生的相关性研究[J]．中华老年医学杂志，2011，30(11): 914-916.
|
| [19] |
帕力达·阿不力孜，周晓辉．代谢综合征与良性前列腺增生的相关性[J]．中国动脉硬化杂志，2011，19(11): 937-940.
|
| [20] |
周哲，王义，蔡建良，等．中老年男性代谢综合征和前列腺增生关系的研究[J]．中华泌尿外科杂志，2012，33(5): 373-377.
|
| [21] |
张祥华，李昕，张争，等．社区男性代谢综合征对下尿路症状影响的研究[J/CD]．中华临床医师杂志(电子版)，2009，3(9): 1484-1490.
|
| [22] |
Ozden C, Ozdal OL, Urgancioglu G, et a1. The correlation between metabo1ic syndrome and prostatic growth in patients with benign prostatic hyperplasia[J].Eur Urol, 2007, 51(1): 199-206.
|
| [23] |
董作亮，张萌，刘金玲．SHBG及其在内分泌代谢性疾病中的研究进展[J]．国际检验医学杂志，2012，33(15): 1843-1844.
|
| [24] |
McVary K.Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology[J]. BJU Int, 2006, 97(Suppl 2): 23-28.
|
| [25] |
Nandeesha H, Koner BC, Dorairajan LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J]. Clinica Chimica Acta, 2006, 370(1-2): 89-93.
|
| [26] |
陈定雄，陈青青，李玉冰．前列腺增生患者合并代谢综合征的临床特点[J]．中华老年学杂志，2010，30(14): 2065-2066.
|